Litemed India: Bringing Drug-Free, Personalised Pain Management Within Reach

November 12, 2026 | Thursday | Features

What began with a personal experience of chronic knee pain has evolved into a medtech venture developing wearable light-therapy devices for everyday pain management. Founded in Hyderabad, Litemed India is combining photobiomodulation technology, clinical research and indigenous manufacturing to make non-invasive pain care more accessible at home.

Problem

Musculoskeletal pain can restrict mobility, affect daily activities and lead to prolonged dependence on pain medication. Conventional treatment options may not always be convenient for continuous home use. Litemed is addressing this gap through wearable, non-invasive light-based pain management.

Product

Its flagship product, CURAPOD, is a wearable device that uses photobiomodulation (low-level red and near-infrared light therapy) to support musculoskeletal pain management. The company has also introduced CURAPOD-M, extending its technology to menstrual pain management and women's health.

Proof

CURAPOD has undergone a double-blind, randomised, placebo-controlled, multicentre clinical study, published in JMIR Biomedical Engineering in April 2026. The company states that the device received CDSCO approval as a Class B medical device in December 2025.

People

Litemed was founded in 2022 by Sri Velliyur (Co-founder and CEO) and Surya Maguluri (Co-founder and CTO). The founding team brings together engineering, pharmaceutical and healthcare experience to develop clinically informed, technology-driven pain management solutions.

Purse

In February 2026, Litemed announced backing from V3 Ventures, 3i Partners and Ideaspring Capital. The company has not disclosed the investment amount on its official website.

Plan

Litemed plans to expand CURAPOD's reach across India while strengthening manufacturing, distribution and clinical partnerships. It is also investing in product and app innovation, expanding its wearable portfolio and exploring international markets, including Europe and the US.

Why it matters

Pain management remains a significant healthcare challenge, particularly for people living with recurring musculoskeletal conditions. Litemed's work represents an effort to bring wearable, non-invasive therapeutic technology into everyday settings while building India's capabilities in medical-device innovation and manufacturing.

FAST FACTS

 

Particulars

Details

Company

Litemed India Private Limited

Brand

Litemed / CURAPOD

Inception

2022

Headquarters

Hyderabad, Telangana

Industry

MedTech, HealthTech, Wearable Medical Devices

Founders

Sri Velliyur and Surya Maguluri

Key Products

CURAPOD, CURAPOD-M

Core Technology

Photobiomodulation / Low-Level Light Therapy

Funding

Investment announced in February 2026; amount not disclosed on company website

Investors

V3 Ventures, 3i Partners, Ideaspring Capital

Website

litemed.co.in

 
 
Disclaimer: This profile is based on publicly available company information, official website disclosures and funding announcements reviewed as of 12th November 2026.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy